MILEFUR stock news
This page provides real-time market news, earnings updates, and company announcements related to Milestone Furniture Ltd. (MILEFUR).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-24 08:03 IST

Oppenheimer Increased its Price Target on Amrize Ltd (AMRZ) to $70 and Maintains an Outperform Rating
Finviz2026-02-22 07:33:41

IREN (IREN) Added to MSCI USA Index, Boosting Exposure to Institutional Investors
Finviz2026-02-22 15:27:39

Mizuho Reiterates Outperform on Alphabet (GOOGL) With $410 Target Price
Finviz2026-02-22 15:27:38

MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results
Finviz2026-02-22 16:03:14

Stifel Adjusts Automatic Data Processing (ADP) Price Target, Keeps Neutral Stance
Finviz2026-02-23 02:21:39

Enigmatig Reports 12.2% Revenue Growth and 68.8% Gross Margin in Fiscal 2025 Following NYSE American Listing
Finviz2026-02-23 10:12:36

TOMI Environmental Solutions Receives Biocidal Product Approvals in Great Britain and Northern Ireland
Finviz2026-02-23 10:33:38
Carmakers push toward ‘eyes-off’ driving, raising questions of safety, liability
101 finance2026-02-23 11:15:15
Offshore Giant Tidewater Deepens Brazil Push With Strategic All-Cash Acquisition
Finviz2026-02-23 11:36:09

C4 Therapeutics Announces First Patient Dosed in Phase 2 MOMENTUM Trial of Cemsidomide, an Oral IKZF1/3 Degrader, in Combination with Dexamethasone for Relapsed/Refractory Multiple Myeloma
Finviz2026-02-23 12:03:46
Exclusive: Reliance Global Completes Enquantum Deal, Starts Path To 51% Ownership
Finviz2026-02-23 12:09:47

Dare Bioscience Announces FDA Clearance of IND for Phase 2 Clinical Study of DARE-HPV, a Potential Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer
Finviz2026-02-23 13:03:44
Culp, Inc. announced that its shares will officially begin trading on the Nasdaq Stock Exchange on March 6, 2026, and will continue to use the existing "CULP" ticker symbol.
老虎证券2026-02-23 13:27:31

Milestone Scientific Launches CompuFlo Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion
Finviz2026-02-23 13:34:18
FDA Accepts Teva's New Long-Acting Schizophrenia Treatment Application
Finviz2026-02-23 13:51:07
Vanda Pharmaceuticals FDA Approval Dawns A New Era For Bipolar And Schizophrenia Treatment
Finviz2026-02-23 14:01:08

Prenetics Launches IM8 Daily Ultimate Essentials PRO - A Clinical Formula with Two New Flavours
Finviz2026-02-23 14:03:47

Kosmos Energy (KOS) Soared by Over 28% This Week. Here is Why
Finviz2026-02-23 15:51:06

PSKY Gears Up to Report Q4 Earnings: What's in Store for the Stock?
Finviz2026-02-23 16:21:40
Walmart To Reward Corporate Staff With 121% Bonus Payout
Finviz2026-02-23 16:48:50

Citi's Simon Hales Reiterates Bullish View on Philip Morris (PM) Growth Outlook
Finviz2026-02-23 17:12:42

National Security Quantum Demand Could Reshape IonQ Outlook
Finviz2026-02-23 18:36:08
Vir Biotechnology, Inc. announces positive progress in dose expansion cohorts for its research and development projects
老虎证券2026-02-23 22:07:05
ArTara Therapeutics, Inc. announces that the company's research and development pipeline is progressing smoothly, and key clinical trials are advancing according to the established schedule.
老虎证券2026-02-23 22:37:03

Stifel Adjusts Automatic Data Processing (ADP) Price Target, Keeps Neutral Stance
Finviz2026-02-23 02:21:39

Enigmatig Reports 12.2% Revenue Growth and 68.8% Gross Margin in Fiscal 2025 Following NYSE American Listing
Finviz2026-02-23 10:12:36

TOMI Environmental Solutions Receives Biocidal Product Approvals in Great Britain and Northern Ireland
Finviz2026-02-23 10:33:38
Carmakers push toward ‘eyes-off’ driving, raising questions of safety, liability
101 finance2026-02-23 11:15:15
Offshore Giant Tidewater Deepens Brazil Push With Strategic All-Cash Acquisition
Finviz2026-02-23 11:36:09

C4 Therapeutics Announces First Patient Dosed in Phase 2 MOMENTUM Trial of Cemsidomide, an Oral IKZF1/3 Degrader, in Combination with Dexamethasone for Relapsed/Refractory Multiple Myeloma
Finviz2026-02-23 12:03:46
Exclusive: Reliance Global Completes Enquantum Deal, Starts Path To 51% Ownership
Finviz2026-02-23 12:09:47

Dare Bioscience Announces FDA Clearance of IND for Phase 2 Clinical Study of DARE-HPV, a Potential Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer
Finviz2026-02-23 13:03:44
Culp, Inc. announced that its shares will officially begin trading on the Nasdaq Stock Exchange on March 6, 2026, and will continue to use the existing "CULP" ticker symbol.
老虎证券2026-02-23 13:27:31

Milestone Scientific Launches CompuFlo Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion
Finviz2026-02-23 13:34:18
FDA Accepts Teva's New Long-Acting Schizophrenia Treatment Application
Finviz2026-02-23 13:51:07
Vanda Pharmaceuticals FDA Approval Dawns A New Era For Bipolar And Schizophrenia Treatment
Finviz2026-02-23 14:01:08

Prenetics Launches IM8 Daily Ultimate Essentials PRO - A Clinical Formula with Two New Flavours
Finviz2026-02-23 14:03:47

Kosmos Energy (KOS) Soared by Over 28% This Week. Here is Why
Finviz2026-02-23 15:51:06

PSKY Gears Up to Report Q4 Earnings: What's in Store for the Stock?
Finviz2026-02-23 16:21:40
Walmart To Reward Corporate Staff With 121% Bonus Payout
Finviz2026-02-23 16:48:50

Citi's Simon Hales Reiterates Bullish View on Philip Morris (PM) Growth Outlook
Finviz2026-02-23 17:12:42

National Security Quantum Demand Could Reshape IonQ Outlook
Finviz2026-02-23 18:36:08
Vir Biotechnology, Inc. announces positive progress in dose expansion cohorts for its research and development projects
老虎证券2026-02-23 22:07:05
ArTara Therapeutics, Inc. announces that the company's research and development pipeline is progressing smoothly, and key clinical trials are advancing according to the established schedule.
老虎证券2026-02-23 22:37:03
MILEFUR stock price change
On the last trading day, MILEFUR stock closed at 27.99 INR, with a price change of 3.67% for the day.
Trade stock futuresMILEFUR stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more